InMed's new proprietary once-a-day delivery system for ophthalmic drugs may also play an important role in enabling other companies’ proprietary ophthalmic drug candidates or re-invigorating the commercial potential of off-patent products that would benefit from a once-a-day dosing regimen. InMed plans to initiate discussion with potential partners to this end.
The most recent cannabis IPO is also one of the most promising based on PI Financial analyst Jason Zandberg’s bullish price target of $2.25 for (TSX.v ABCN) ABcann Global Corp.
The next major marijuana success story is about hit the markets ABcann Global (TSX.v ABCN) It’s a mid-size marijuana grower that’s on it’s way to major success. It’s already implementing one of the largest expansions in the world right now. READ THE REPORT
Courtesy of Ted Chung Snoop Dogg With the legal cannabis industry generating $6.9 billion in sales in 2016, up 34% from 2015, it’s a no-brainer to say that much is at stake as the business inevitably grows. Much like the independent movie biz, the cannabis industry attracts investors looking for high-risk, high-reward investments, and as marijuana goes more mainstream, so does the funding mechanisms for the industry’s businesses.
Medical marijuana companies will likely tap the Canadian bond market to fund growth as investors become more comfortable with the industry and the federal government gets set to legalize the drug by next year.
“There would be an appetite for more traditional debt arrangements and, given that leading cannabis companies have significant assets now, this may be one direction that we see the market go in the future,” said Cam Battley, executive vice president of Aurora Cannabis Inc., a licensed marijuana producer in Mountain View County, Alberta. “I suspect we’re headed in that direction right now.”
The Seed Investor looks at Canada’s C$22 billion cannabis industry with a review of recreational cannabis in Canada and how licensed producers are gearing up to meet demand. Find out how investors can capitalize on these trends.
MONTREAL — The Canadian government on Thursday announced new legislation legalizing marijuana, fulfilling one of Prime Minister Justin Trudeau’s major campaign promises. Canada has anticipated the law will take effect in the summer of 2018. The new federal laws will make the possession of small amounts of pot legal throughout the country and will also establish broad guidelines concerning who can grow, sell and buy the drug. Many specifics regarding who can possess or sell will be left to the individual provinces. Canada legalized marijuana for some medicinal uses in 2001. For more info: click here
Aphria Inc. has been soaring since its graduation to the TSX last month. The company now has a $1.1 billion market cap and could pass Canopy Growth Corp. with its $1.74 billion market cap over the next few months. There’s no question Canopy stock has slowed down when compared to its peers like Aphria and Aurora Cannabis Inc
The post Could Aphria Inc. or Aurora Cannabis Inc. Dethrone Canopy Growth Corp.? appeared first on Marijuana Industry News.
Two weeks ago, the government of Argentina gained final legislative approval of a bill allowing for the medicinal use of cannabis oil. This legislation also permits cannabis to be grown for both research and therapeutic purposes. The unanimously approved bill helps to establish a means for scientific exploration of the effectiveness of marijuana to treat numerous diseases, as well as a way for Argentina to provide medical cannabis to patients free of charge.